CORC

在结果中检索

CORC

浏览/检索结果: 共45条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
An injectable and tumor-specific responsive hydrogel with tissue-adhesive and nanomedicine-releasing abilities for precise locoregional chemotherapy 期刊论文
2019, 卷号: 96, 页码: 123-136
作者:  Wu Di;  Shi Xiaoguang;  Zhao Fuli;  Chilengue Sergio Tomas Fernando;  Deng Liandong
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout 期刊论文
2019
作者:  Zhang Fengchun
收藏  |  浏览/下载：38/0  |  提交时间：2020/01/03
Injectable, Biodegradable, Thermosensitive Nanoparticles-Aggregated Hydrogel with Tumor-Specific Targeting, Penetration, and Release for Efficient Postsurgical Prevention of Tumor Recurrence 期刊论文
2019, 卷号: 11, 期号: 22, 页码: 19700-19711
作者:  Liu, Huiming;  Shi, Xiaoguang;  Wu, Di;  Khshen, Frewein Kahsay;  Deng, Liandong
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection 期刊论文
2019, 卷号: 28, 期号: 2, 页码: 341-348
作者:  Takeuchi, Fumihiko;  Kukimoto, Iwao;  Li, Zhiqiang;  Li, Shuang;  Li, Ni
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Host-guest supramolecular hydrogel based on nanoparticles: co-delivery of DOX and siBcl-2 for synergistic cancer therapy 期刊论文
2019, 卷号: 30, 期号: 10, 页码: 877-893
作者:  Peng, Dan;  Gao, Huijie;  Huang, Pingsheng;  Shi, Xiaoguang;  Zhou, Junhui
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
2019, 卷号: 14, 期号: 5, 页码: 867-875
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Chinese clinical guidelines for continuous glucose monitoring (2018 edition) 期刊论文
2019, 卷号: 35, 期号: 6, 页码: e3152
作者:  Bao Yuqian;  Chen Li;  Chen Liming;  Dou Jingtao;  Gao Zhengnan
收藏  |  浏览/下载：37/0  |  提交时间：2020/01/03
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer 期刊论文
2018, 卷号: 122, 页码: 32-37
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace